Science Explorer Interactive view Map
Company · Warsaw · Poland

GlaxoSmithKline (Poland)

Research works
21
▼ 73% vs 2013–17
Citations
201
9.7 per fractional work
Top-10% rate
13.9%
record average 16.5%
Open access
58%
world 28%

Not ranked overall: GlaxoSmithKline (Poland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.14× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.43× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 7.24× its world share, 0 worksImmunology and Micro…Neuroscience: 1.32× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 8.83× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.14× its world share, 0 worksComputer ScienceEnvironmental Science: 2.59× its world share, 0 worksEnvironmental ScienceMathematics: 2.64× its world share, 0 worksMathematicsMedicine: 2.17× its world share, 2 worksMedicineBusiness, Management and Accounting: 1.99× its world share, 0 worksBusiness, Management…Decision Sciences: 0.63× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.50× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.13× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.8×. Every wedge is a field page.

Which research topics does GlaxoSmithKline (Poland) publish most on?

By volume in 2022–2025: Biomedical Text Mining and Ontologies, Effects and risks of endocrine disrupting chemicals, Pneumonia and Respiratory Infections and Pharmacovigilance and Adverse Drug Reactions.

  1. 1 Biomedical Text Mining and Ontologies Molecular Biology 0 works
  2. 2 Effects and risks of endocrine disrupting chemicals Health, Toxicology and Mutagenesis 0 works
  3. 3 Pneumonia and Respiratory Infections Epidemiology 0 works
  4. 4 Pharmacovigilance and Adverse Drug Reactions Toxicology 0 works
  5. 5 Heparin-Induced Thrombocytopenia and Thrombosis Surgery 0 works
  6. 6 Family Business Performance and Succession Organizational Behavior and Human Resource Management 0 works
  7. 7 Medical Device Sterilization and Disinfection Microbiology 0 works
  8. 8 Entrepreneurship Studies and Influences Management of Technology and Innovation 0 works
  9. 9 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  10. 10 SARS-CoV-2 detection and testing Infectious Diseases 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available57.7%not open42.3%

World: 28% of research is openly available.

with international co-authors64.2%domestic only35.8%

World: 19% is written across borders.

How has GlaxoSmithKline (Poland)'s research output changed?

Output in 2018–2022 was 73% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Warsaw

All research institutions in Warsaw

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.